Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0086543 (
cataract
)
29,165
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The metabolic transformation of acetaminophen to N-acetyl-p-benzoquinone imine by cytochrome P450 enzymes (e.g.,
cytochrome P450 1A2
) is a prerequisite for acetaminophen-induced
cataract
formation in mice. Aromatic hydrocarbons, such as beta-naphthoflavone, induce
cytochrome P450 1A2
in C57BL6 mice via the mediation of the aromatic hydrocarbon receptor and render the animals susceptible to
cataract
formation by acetaminophen administration but not in DBA2 mice which do not respond to
cytochrome P450 1A2
induction by these compounds. Polycyclic hydrocarbons, such as acenaphthylene, were recently found to induce
cytochrome P450 1A2
gene expression in young DBA2 mice by aromatic hydrocarbon receptor-independent pathways. In this work, we investigated whether enhanced metabolism of acetaminophen to N-acetyl-p-benzoquinone by
cytochrome P450 1A2
induction by acenaphthylene could produce
cataract
in young DBA2 mice. Fifteen-day-old DBA2 mice were pretreated with two intraperitoneal injections of acenaphthylene and, 24 hr later, with one injection of acetaminophen. In most mice,
cataract
developed 18-24 hr after acenaphthylene injection. Acenaphthylene treatment of young DBA2 mice resulted in a 2-fold increase in
cytochrome P450 1A2
-dependent methoxyresorufin O-demethylase activity in the liver. These results support the hypothesis that the aromatic hydrocarbon receptor-independent induction of
cytochrome P450 1A2
enzyme leads to accumulation of sufficient N-acetyl-p-benzoquinone in the liver and
cataract
development in the eye.
...
PMID:Acetaminophen produces cataract in DBA2 mice by Ah receptor-independent induction of CYP1A2. 1097 29